Section Arrow
PRPO.NASDAQ
- Precipio
Quotes are at least 15-min delayed:2026/09/02 09:56 EDT
Regular Hours
Last
 27.94
+0.175 (+0.63%)
Day High 
28.16 
Prev. Close
27.765 
1-M High
32.57 
Volume 
16.70K 
Bid
27.81
Ask
28.1
Day Low
27.25 
Open
27.93 
1-M Low
21.48 
Market Cap 
49.70M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 29.37 
20-SMA 26.37 
50-SMA 24.78 
52-W High 33.63 
52-W Low 16 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.62/0.39
Enterprise Value
52.71M
Balance Sheet
Book Value Per Share
8.24
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
24.05M
Operating Revenue Per Share
6.12
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BIAFbioAffinity Technologies Inc10.6716+4.0816+61.94%-- 
OPKOPKO Health1.63+0.11+7.24%-- 
PSNLPersonalis17.05-0.01-0.06%-- 
QUCYQuantum Cyber NV1.57+0.09+6.08%-- 
DHRDanaher Corp212.585+5.655+2.73%36.89PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.